Wen Nuan, Osorio Claudia E, Brew-Appiah Rhoda A T, Mejías Jaime H, Alam Tariq, Kashyap Samneet, Reinbothe Steffen, Reinbothe Christiane, Moehs Charles P, von Wettstein Diter, Rustgi Sachin
Department of Crop and Soil Sciences, Washington State University, Pullman, WA, United States.
Instituto de Investigaciones Agropecuarias, INIA Carillanca, Temuco, Chile.
Front Nutr. 2022 Mar 3;9:847635. doi: 10.3389/fnut.2022.847635. eCollection 2022.
Wheat is a major source of energy and nutrition worldwide, but it is also a primary cause of frequent diet-induced health issues, specifically celiac disease, for which the only effective therapy so far is strict dietary abstinence from gluten-containing grains. Wheat gluten proteins are grouped into two major categories: high-molecular-weight glutenin subunits (HMWgs), vital for mixing and baking properties, and gliadins plus low-molecular-weight glutenin subunits (LMWgs) that contain the overwhelming majority of celiac-causing epitopes. We put forth a hypothesis that eliminating gliadins and LMWgs while retaining HMWgs might allow the development of reduced-immunogenicity wheat genotypes relevant to most gluten-sensitive individuals. This hypothesis stems from the knowledge that the molecular structures and regulatory mechanisms of the genes encoding the two groups of gluten proteins are quite different, and blocking one group's transcription, without affecting the other's, is possible. The genes for gliadins and LMWgs have to be de-methylated by 5-methylcytosine DNA glycosylase/lyase (DEMETER) and an iron-sulfur (Fe-S) cluster biogenesis enzyme (DRE2) early during endosperm development to permit their transcription. In this study, a TILLING (Targeting Induced Local Lesions IN Genomes) approach was undertaken to identify mutations in the homoeologous () and genes in common and durum wheat. Lines with mutations in these genes were obtained that displayed reduced content of immunogenic gluten proteins while retaining essential baking properties. Although our data at first glance suggest new possibilities for treating celiac disease and are therefore of medical and agronomical interest, it also shows that inducing mutations in the and genes analyzed here affected pollen viability and germination. Hence there is a need to develop other approaches in the future to overcome this undesired effect.
小麦是全球主要的能量和营养来源,但也是饮食引发的常见健康问题的主要原因,尤其是乳糜泻,迄今为止,针对该病唯一有效的治疗方法是严格避免食用含麸质谷物。小麦面筋蛋白主要分为两大类:对混合和烘焙特性至关重要的高分子量谷蛋白亚基(HMWgs),以及含有绝大多数引发乳糜泻表位的醇溶蛋白和低分子量谷蛋白亚基(LMWgs)。我们提出一个假设,即消除醇溶蛋白和LMWgs同时保留HMWgs,可能会培育出对大多数麸质敏感个体具有较低免疫原性的小麦基因型。这一假设源于这样的认识:编码这两类面筋蛋白的基因的分子结构和调控机制差异很大,并且有可能在不影响另一类基因转录的情况下阻断其中一类基因的转录。在胚乳发育早期,醇溶蛋白和LMWgs的基因必须被5-甲基胞嘧啶DNA糖基化酶/裂解酶(DEMETER)和一种铁硫(Fe-S)簇生物合成酶(DRE2)去甲基化,以允许它们转录。在本研究中,采用了靶向基因组诱导局部损伤(TILLING)方法来鉴定普通小麦和硬粒小麦中同源的()和基因的突变。获得了这些基因发生突变的品系,这些品系显示出免疫原性面筋蛋白含量降低,同时保留了基本的烘焙特性。尽管我们的数据乍一看为治疗乳糜泻提供了新的可能性,因此具有医学和农学意义,但它也表明,在此分析的和基因中诱导突变会影响花粉活力和萌发。因此,未来有必要开发其他方法来克服这种不良影响。